Healthy volunteers needed to test new heart Drug's safety

NCT ID NCT07551167

First seen Apr 25, 2026 · Last updated May 14, 2026 · Updated 7 times

Summary

This early-stage study tests the safety and tolerability of a new drug called HRS-5765 in 74 healthy adults aged 18-65. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and how the drug moves through the body. This study does not aim to treat any condition, but to gather important safety information before testing in patients with heart failure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.